ERIS Lifesciences consolidated net profit declines 25.80% in the September 2024 quarter

Net profit of ERIS Lifesciences declined 25.80% to Rs 91.59 crore in the quarter ended September 2024 as against Rs 123.43 crore during the previous quarter ended September 2023. Sales rose 47.64% to Rs 738.95 crore in the quarter ended September 2024 as against Rs 500.52 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	738.95	500.52	48
OPM %	35.80	36.19	-
PBDT	209.59	168.33	25
PBT	129.11	126.24	2
NP	91.59	123.43	-26